Resistin enhances angiogenesis in osteosarcoma via the MAPK signaling pathway

Over the last two decades, there have been no significant changes in patient outcomes in relation to the treatment of osteosarcoma, an aggressive malignant neoplasm. It is known that vascular endothelial growth factor-A (VEGF-A) plays a crucial role in angiogenesis and in osteosarcoma. Moreover, VEG...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Hsiao-Chi, Cheng, Shih-Ping, Han, Chien-Kuo, Huang, Yuan-Li, Wang, Shih-Wei, Lee, Jie-Jen, Lai, Cheng-Ta, Fong, Yi-Chin, Tang, Chih-Hsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874472/
https://www.ncbi.nlm.nih.gov/pubmed/31719210
http://dx.doi.org/10.18632/aging.102423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874472/
https://www.ncbi.nlm.nih.gov/pubmed/31719210
http://dx.doi.org/10.18632/aging.102423

Ejemplares similares